Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 5 May 2026 - Mint
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 5 May 2026Mint
India's healthcare expansion faces a critical talent crunch, says Alisha Moopen
Aster DM Healthcare is gearing up for a significant upgrade, targeting a capacity of 15,000 beds by the fiscal year 2029. With plans driven by both natural growth and an ambitious merger, the company is optimistic about a surge in revenue and enhanced profit margins.
Laurus Labs Q4 Results: Cons PAT increased 19% to Rs 279 crore, revenue rises 5%
Laurus Labs reported a 19% year-on-year jump in net profit to Rs 279 crore for the March quarter, with revenue rising 5% to Rs 1,812 crore. Full-year net profit surged 148% to Rs 889 crore, driven by strong growth in its CDMO and Generics divisions. The company also announced an interim dividend of Rs 1.20 per share.
Star Health shares rally 13% after Q4 net profit soars to Rs 111 crore, beats estimate
Star Health and Allied Insurance Company's shares surged over 13% after reporting a significant jump in Q4 FY26 net profit to Rs 111.34 crore, exceeding brokerage estimates. The insurer also saw a 14% year-on-year growth in net earned premium and a narrowing of underwriting losses, indicating improved operating efficiency and profitability.
Where to invest now: SBI MF prefers large caps, pharma, PSU banks
Ruchit Mehta, Head of Research at SBI Mutual Fund, prefers CDMO and hospital plays within pharma, citing stronger growth prospects over generics. He sees large caps as attractive on valuations, while midcaps require selectivity amid earnings risks. PSU banks may outperform in the near term due to stronger loan growth, but asset quality risks could emerge over the next 2–3 quarters if global disruptions persist.
Stocks to Buy: Citi projects 20% upside for a stock that Mutual Funds lapped up in March
Citi expects Anthem Bio's revenue to grow at a 19% CAGR over financial year 2026-2028 and its Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) to grow at a 22% CAGR during the same timeframe.
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12% - scanx.trade
Nippon India Mutual Fund Increases Stake in Syngene International to 7.12%scanx.trade
MF Favourites take a hit: 14 smallcap stocks slide up to 50% in 3 months
Despite rising mutual fund stakes, several smallcap stocks have plunged up to 47% in 2026, highlighting market uncertainty and raising questions on whether these beaten-down picks offer value or further downside.
425% rally in one year! Multibagger stock hits upper circuit on launch of ₹50 million innovation fund
Take Solutions' stock reached a 2% upper circuit at ₹42.04 after announcing a ₹50 million Innovation Fund aimed at investing in AI and health startups. This initiative emphasizes the company's shift towards technology-driven business models to create long-term stakeholder value.
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 17 March 2026 - Mint
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 17 March 2026Mint
Kotak Mahindra Mutual Fund acquires stake in this recently listed healthcare stock
Kotak Mahindra Mutual Fund (KMMF) has raised its stake in the North Indian hospital network Park Medi World Limited to more than 5%. The fund purchased 175,164 shares, bringing its total ownership to 5.0393%, which necessitates a regulatory announcement in accordance with SAST regulations.
Growth Leaders: 10 midcap stocks with stellar 50%+ YoY sales gains
Several NSE midcap companies delivered strong growth in the December 2025 quarter, with sales rising over 50% year-on-year. Firms across sectors such as metals, real estate, energy and healthcare reported sharp demand-led expansion, highlighting strong business momentum and growth potential.